Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Alcohol Use Disorder Clinical Trials

A listing of Alcohol Use Disorder medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (5) clinical trials

A clinical trial to evaluate treatments using Placebo Oral Tablet, N-Acetylcysteine, Gabapentin for patients

Bipolar disorder (BD) is the Axis I psychiatric condition most strongly associated with substance use disorder (SUD); diagnostic co-occurrence is particularly high between BD and alcohol use disorder (AUD). Individuals with co-occurring SUD and BD (SUD+BD) have substantially worse clinical outcomes than those with either BD or SUD alone. Nonetheless, ...


Patients are needed to participate in a clinical research study of Bipolar II Disorder, Cannabis Use Disorder, Drug abuse, Bipolar I Disorder to evaluate Placebo Oral Capsule, Gabapentin

Bipolar disorder (BD) is the Axis I condition most strongly associated with cannabis use disorder (CUD); there is a six-fold increase in the prevalence of CUD in individuals with BD relative to the general population. Individuals with co-occurring CUD and BD (CUD+BD) have substantially worse clinical outcomes than those with ...


A clinical trial sponsored by Yale University for a research study for the treatment of Post-Traumatic Stress Disorder, Alcohol abuse

This is a randomized, controlled trial with 50 veterans diagnosed with post-traumatic stress disorder (PTSD) and comorbid alcohol dependence. Veterans will be randomized to receive either zonisamide (400 mg) or placebo for 12 weeks in a double blind fashion. Randomization will be done using 3:1 ratio and will be performed ...


A clinical research study of Varenicline plus Naltrexone, Varenicline for the treatment of Alcohol Use Disorder, Tobacco abuse

This study is a double-blind, randomized clinical trial using a two group medication design consisting of the combination of VAR (1 mg twice daily) + NTX (50 mg once daily) and VAR (1 mg twice daily) + PLA (matched to NTX), for smoking cessation in a sample of heavy drinking ...